Therapeutic prospects of microRNAs in cancer treatment through nanotechnology

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Drug Delivery and Translational Research

• Publication date

  2017-11-28

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1007/s13346-017-0440-1PMID 29185148
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma

  2017cited by this paper
• Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale?

  2017cited by this paper
• Electrochemical miRNA Biosensors: The Benefits of Nanotechnology

  2017cited by this paper
• Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.

  2017cited by this paper
• MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: Current progress in genetic association studies, expression profiling, and translational research

  2017cited by this paper
• Dual-mode electrochemical analysis of microRNA-21 using gold nanoparticle-decorated MoS2 nanosheet.

  2017cited by this paper
• miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.

  2017cited by this paper
• MicroRNA-29: A Crucial Player in Fibrotic Disease

  2017cited by this paper
• Self‐immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy

  2017cited by this paper
• Microparticles shed from multidrug resistant breast cancer cells provide a parallel survival pathway through immune evasion

  2017cited by this paper
• Electrochemical DNA sandwich biosensor based on enzyme amplified microRNA-21 detection and gold nanoparticles.

  2017cited by this paper
• A novel mechanism governing the transcriptional regulation of ABC transporters in MDR cancer cells

  2017cited by this paper
• MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD.

  2017cited by this paper
• Rapid and sensitive detection of microRNA via the capture of fluorescent dyes-loaded albumin nanoparticles around functionalized magnetic beads.

  2017cited by this paper
• Challenges and strategies in anti-cancer nanomedicine development: An industry perspective.

  2017cited by this paper
• Traceable microRNA-124 loaded nanoparticles as a new promising therapeutic tool for Parkinson's disease

  2016cited by this paper
• Isolation of Human CD138+ Microparticles from the Plasma of Patients with Multiple Myeloma1

  2016cited by this paper
• To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?

  2016cited by this paper
• Deciphering Cell-to-Cell Communication in Acquisition of Cancer Traits: Extracellular Membrane Vesicles Are Regulators of Tissue Biomechanics

  2016cited by this paper
• Recent Advances in Biosensor Technology for Potential Applications – An Overview

  2016cited by this paper
• Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy

  2016cited by this paper
• MicroRNA and Heart Failure

  2016cited by this paper
• The Role of MicroRNAs in Myeloproliferative Neoplasia

  2016cited by this paper
• MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases

  2016cited by this paper
• Opportunities and Challenges in Nano-structure Mediated Drug Delivery: Where Do We Stand?

  2016cited by this paper
• Nanoparticle Based Delivery of miRNAs to Overcome Drug Resistance inBreast Cancer

  2016cited by this paper
• A novel method to detect translation of membrane proteins following microvesicle intercellular transfer of nucleic acids.

  2016cited by this paper
• Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?

  2016cited by this paper
• Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors.

  2015cited by this paper
• Recent trends in electrochemical microRNA biosensors for early detection of cancer

  2015cited by this paper
• Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.

  2015cited by this paper
• Cancer biomarker detection: recent achievements and challenges.

  2015cited by this paper
• The Present and the Future of Degradable Dendrimers and Derivatives in Theranostics.

  2015cited by this paper
• Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation

  2015cited by this paper
• C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer

  2015cited by this paper
• Developing nanocrystals for cancer treatment.

  2015cited by this paper
• Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.

  2014cited by this paper
• Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation

  2014cited by this paper
• Proteome analysis of multidrug-resistant, breast cancer–derived microparticles

  2014cited by this paper
• Therapeutic targeting of microRNAs: current status and future challenges

  2014cited by this paper
• Layered gadolinium-based nanoparticle as a novel delivery platform for microRNA therapeutics

  2014cited by this paper
• Epigenetic silencing of MicroRNA-503 regulates FANCA expression in non-small cell lung cancer cell.

  2014cited by this paper
• Microparticles Mediate the Intercellular Regulation of microRNA-503 and Proline-Rich Tyrosine Kinase 2 to Alter the Migration and Invasion Capacity of Breast Cancer Cells

  2014cited by this paper
• MicroRNAs as novel biological targets for detection and regulation.

  2014cited by this paper
• Nanotopography Directs Mesenchymal Stem Cells to Osteoblast Lineage Through Regulation of microRNA‐SMAD‐BMP‐2 Circuit

  2014cited by this paper
• Target-responsive DNA/RNA nanomaterials for microRNA sensing and inhibition: the jack-of-all-trades in cancer nanotheranostics?

  2014cited by this paper
• Prognostic value of phospho‐Akt in patients with non‐small cell lung carcinoma: A meta‐analysis

  2014cited by this paper
• Nanotechnology-based strategies for the detection and quantification of microRNA.

  2014cited by this paper
• Nanomaterials-Based Sensing Strategies for Electrochemical Detection of MicroRNAs

  2014cited by this paper
• Key principles of miRNA involvement in human diseases

  2014cited by this paper
• Gold nanoparticles: emerging paradigm for targeted drug delivery system.

  2013cited by this paper
• MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R

  2013cited by this paper
• Progress in microRNA delivery.

  2013cited by this paper
• Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges

  2013cited by this paper
• The role of miR-145 in microvasculature.

  2013cited by this paper
• A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells.

  2013cited by this paper
• MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines

  2013cited by this paper
• Histone Deacetylases and NF-kB Signaling Coordinate Expression of CX3CL1 in Epithelial Cells in Response to Microbial Challenge by Suppressing miR-424 and miR-503

  2013cited by this paper
• Nanotechnology in cancer therapy

  2013cited by this paper
• MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma

  2013cited by this paper
• miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.

  2013cited by this paper
• Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways.

  2013cited by this paper
• Second generation liposomal cancer therapeutics: transition from laboratory to clinic.

  2013cited by this paper
• Clinical applications of microRNAs

  2013cited by this paper
• Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer

  2012cited by this paper
• Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

  2012cited by this paper
• miRNA in Wound Inflammation and Angiogenesis

  2012cited by this paper
• Microparticle‐associated nucleic acids mediate trait dominance in cancer

  2012cited by this paper
• Proof of concept for next-generation nanoparticle drugs in humans

  2012cited by this paper
• Microparticle conferred microRNA profiles - implications in the transfer and dominance of cancer traits

  2012cited by this paper
• Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles

  2012cited by this paper
• The Business of RNAi Therapeutics in 2012

  2012cited by this paper
• Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research

  2012cited by this paper
• MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship

  2012cited by this paper
• Nanoparticles for Targeted and Temporally Controlled Drug Delivery

  2012cited by this paper
• Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis.

  2012cited by this paper
• MicroRNA regulation in angiogenesis.

  2011cited by this paper
• Recent Advance in Biosensors for microRNAs Detection in Cancer

  2011cited by this paper
• MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease

  2011cited by this paper
• Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.

  2011cited by this paper
• Nucleic acid-gold nanoparticle conjugates as mimics of microRNA.

  2011cited by this paper
• MicroRNA therapeutics

  2011cited by this paper
• Targeted delivery of antisense inhibitor of miRNA for antiangiogenesis therapy using cRGD-functionalized nanoparticles.

  2011cited by this paper
• Polymer--drug conjugates as nano-sized medicines.

  2011cited by this paper
• Next-Generation Sequencing of MicroRNAs for Breast Cancer Detection

  2011cited by this paper
• Nanopore-based detection of circulating microRNAs in lung cancer patients

  2011cited by this paper
• Therapeutic Inhibition of miR-208a Improves Cardiac Function and Survival During Heart Failure

  2011cited by this paper
• Alterations of microRNAs and their targets are associated with acquired resistance of MCF‐7 breast cancer cells to cisplatin

  2010cited by this paper
• Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1.

  2010cited by this paper
• Nanomaterial standards for efficacy and toxicity assessment.

  2010cited by this paper
• Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation

  2010cited by this paper
• MicroRNA: Biogenesis, Function and Role in Cancer

  2010cited by this paper
• On firm ground: IP protection of therapeutic nanoparticles

  2010cited by this paper
• Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.

  2010cited by this paper
• microRNA and Cancer

  2010cited by this paper
• RNAi-based therapeutics–current status, challenges and prospects

  2009cited by this paper
• Strategies for profiling MicroRNA expression

  2009cited by this paper
• Knocking down barriers: advances in siRNA delivery

  2009cited by this paper
• Cationic nanoparticles induce nanoscale disruption in living cell plasma membranes.

  2009cited by this paper
• A phase I pharmacokinetic (PK) study of MBP-426, a novel liposome encapsulated oxaliplatin.

  2009cited by this paper

• MicroRNA biomarkers for predicting treatment response and resistance to bevacizumab in cancer.

  2025cites this paper
• MicroRNA nanoformulation: a promising approach to anti-tumour activity

  2025cites this paper
• A Review of Nanotechnology in microRNA Detection and Drug Delivery

  2024cites this paper
• Interplay of nano-based delivery systems and protein signalling in ameliorating lung diseases

  2024cites this paper
• Therapeutic Efficacy of Nanocarrier‐Mediated Inhalable Gene Transfection for Lung Cancer

  2024cites this paper
• Layered Double Hydroxide-Loaded miR-30a for the Treatment of Breast Cancer In Vitro and In Vivo

  2023cites this paper
• Exosome‑delivered miR‑486‑3p inhibits the progression of osteosarcoma via sponging CircKEAP1/MARCH1 axis components

  2023cites this paper
• Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions

  2023cites this paper
• Metal‐Organic Frameworks for Gene Therapy and Detection

  2023cites this paper
• A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA

  2022cites this paper
• Inhibition of miR-98-5p promotes high glucose-induced suppression of preosteoblast proliferation and differentiation via the activation of the PI3K/AKT/GSK3β signaling pathway by targeting BMP2

  2022cites this paper
• MiR-1306-5p promotes cell proliferation and inhibits cell apoptosis in acute myeloid leukemia by downregulating PHF6 expression.

  2022cites this paper
• Improved understanding of gastrointestinal stromal tumors biology as a step for developing new diagnostic and therapeutic schemes.

  2021cites this paper
• Silencing of circular RNA PUM1 inhibits clear cell renal cell carcinoma progression through the miR-340-5p/FABP7 axis

  2021cites this paper
• High expression of microRNA-1266 in hepatocellular carcinoma is associated with poor prognosis of patients and biological cell growth.

  2021cites this paper
• Nanocarriers for protein and peptide delivery: Recent advances and progress

  2021cites this paper
• miR-338-5p-ZEB2 axis in Diagnostic, Therapeutic Predictive and Prognostic Value of Gastric Cancer

  2021cites this paper
• microRNA-877-5p exerts tumor-suppressive functions in prostate cancer through repressing transcription of forkhead box M1

  2021cites this paper
• Targeting Chronic Lung Diseases Using Advanced Drug Delivery Systems

  2021cites this paper
• MiR‐195‐5p represses inflammation, apoptosis, oxidative stress, and endoplasmic reticulum stress in sepsis‐induced myocardial injury by targeting activating transcription factor 6

  2021cites this paper
• Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver

  2020cites this paper
• Nucleic Acid-Based Approaches for Tumor Therapy

  2020cites this paper
• Emerging molecular functions of microRNA-124: Cancer pathology and therapeutic implications.

  2020cites this paper
• Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.

  2020cites this paper
• The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways

  2020cites this paper
• Peptide-conjugated liposomes for targeted miR-34a delivery to suppress breast cancer and cancer stem-like population

  2020cites this paper
• miRNA nanotherapeutics: potential and challenges in respiratory disorders

  2020cites this paper
• Norepinephrine‐CREB1‐miR‐373 axis promotes progression of colon cancer

  2020cites this paper
• A graphene oxide fluorescent sensing platform for sensitive and specific detecting biomarker of radiation-resistant nasopharyngeal carcinoma.

  2019cites this paper
• Delivery of therapeutic miRNA using polymer-based formulation

  2019cites this paper
• Formulation and characterization of glibenclamide and quercetin-loaded chitosan nanogels targeting skin permeation.

  2019cites this paper
• Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system.

  2019cites this paper
• Downregulation of miR-205 contributes to epithelial–mesenchymal transition and invasion in triple-negative breast cancer by targeting HMGB1–RAGE signaling pathway

  2019cites this paper
• Emerging trends in the novel drug delivery approaches for the treatment of lung cancer.

  2019cites this paper
• miR-146a-5p targets interleukin-1 receptor-associated kinase 1 to inhibit the growth, migration, and invasion of breast cancer cells

  2018cites this paper